19.02.2016 MediClin AG  DE0006595101

DGAP-News: MediClin AG: Group sales increased by EUR 17.3 mill. up to EUR 555.3 mill.; preliminary Group operating result amounts to EUR 23.6 mill.


 
DGAP-News: MediClin AG / Key word(s): Preliminary Results MediClin AG: Group sales increased by EUR 17.3 mill. up to EUR 555.3 mill.; preliminary Group operating result amounts to EUR 23.6 mill. 19.02.2016 / 13:10 The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Group sales increased by EUR 17.3 mill. up to EUR 555.3 mill.; preliminary Group operating result amounts to EUR 23.6 mill. Offenburg, February 19, 2016 -MEDICLIN Aktiengesellschaft (MediClin) achieved Group sales of EUR 555.3 mill. in the FY 2015. The sales plus was EUR 17.3 mill. or 3.2% against previous year. The preliminary Group operating result (Group-EBIT) increased from EUR 15.6 mill. to EUR 23.6 mill. and the preliminary result attributable to shareholders of MediClin AG from EUR 8.5 mill. to EUR 16.5 mill. Earnings per share account to EUR 0.35 (previous year: EUR 0.18). The largest share of sales growth posted the post-acute segment with EUR 16.5 mill. Especially the clinics contributed to this development which offer additional medical services of acute-neurology and acute-psychosomatic in the scope of an integrated care concept. The segment achieved sales of EUR 330.9 mill. (previous year: EUR 314.4 mill.) The nursing care business area accounted for EUR 14.1 mill. contributing EUR 1.0 mill. to sales growth. Sales of the acute segment amounted to EUR 206.7 mill., thus being EUR 0.6 mill. below previous years value, because only eight medical care centres added to sales growth instead of ten as in the previous year. Without the sales decrease of the medical care centres sales in the acute segment would be up by EUR 0.7 mill. The segment results of the post-acute and acute segment increased by EUR 4.0 mill. respectively EUR 0.5 mill. against previous year. In the post-acute segment higher staff costs could be more than compensated by significantly higher sales and lower material costs compared to the previous year. In the acute segment lower material costs and staff costs led to an increase of result despite a slight decrease in sales. In the FY 2015 about EUR 27.0 mill. (previous year: EUR 21,0 mill.) were invested in capital expenditure including EUR 2.7 mill. (previous year: EUR 4.4 mill.) subsidies. As of December 31, 2015 cash and cash equivalents amounted to EUR 29.5 mill. (31.12.2014: EUR 26.3 mill.); the equity ratio was 51.3% (31.12.2014: 48.2%). The press conference and the analysts and investors conference will take place in Frankfurt on March 23, 2015. From that date onwards the annual report 2015 will be available under www.mediclin.de in German and English. About MediClin AG (Ticker: MED; WKN: 659 510) MediClin AG is a nation-wide clinic operator and large provider of services in the area of Psycho- and Neuro-sciences as well as Orthopaedic. With 34 clinics, 7 nursing care facilities and 8 medical care centres in 11 federal states MediClin has a total capacity of approximately 8,000 beds. MediClins' facilities include acute care clinics, i.e., general hospitals, special treatment facilities, specialised hospitals and clinics for post-acute treatment and medical rehabilitation. MediClin has approximately 9,000 employees. MediClin ─ a company of the Asklepios Group --------------------------------------------------------------------------- 19.02.2016 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: MediClin AG Okenstraße 27 77652 Offenburg Germany Phone: +49 (0)781 488-189 Fax: +49 (0)781 488-184 E-mail: [email protected] Internet: www.mediclin.de ISIN: DE0006595101 WKN: 659510 Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart End of News DGAP News Service --------------------------------------------------------------------------- 438645 19.02.2016


Die wichtigsten Finanzdaten auf einen Blick
  2017 2018 2019 2020 2021 2022 2023e
Umsatzerlöse1 609,08 645,11 673,09 659,86 673,14 704,70 730,07
EBITDA1,2 27,01 37,35 93,58 77,50 85,22 90,92 98,73
EBITDA-Marge3 4,43 5,79 13,90 11,74 12,66 12,90
EBIT1,4 6,62 15,06 22,41 0,15 11,56 19,52 12,72
EBIT-Marge5 1,09 2,33 3,33 0,02 1,72 2,77 1,74
Jahresüberschuss1 3,96 7,76 9,68 -0,04 1,49 9,72 -10,72
Netto-Marge6 0,65 1,20 1,44 -0,01 0,22 1,38 -1,47
Cashflow1,7 19,34 29,77 69,59 118,69 81,97 34,64 78,00
Ergebnis je Aktie8 0,08 0,16 0,20 -0,19 0,03 0,20 -0,23
Dividende8 0,05 0,05 0,05 0,00 0,00 0,00 0,00
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2023 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: PricewaterhouseCoopers

INVESTOR-INFORMATIONEN
©boersengefluester.de
Mediclin
WKN Kurs in € Einschätzung Börsenwert in Mio. €
659510 2,700 Halten 128,25
KGV 2025e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
10,38 19,24 0,53 20,30
KBV KCV KUV EV/EBITDA
0,65 1,64 0,18 1,50
Dividende '22 in € Dividende '23e in € Div.-Rendite '23e
in %
Hauptversammlung
0,00 0,00 0,00 06.06.2024
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
02.05.2024 31.07.2024 04.11.2024 26.03.2024
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
4,98% -0,92% -1,46% -11,76%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu MediClin AG  ISIN: DE0006595101 können Sie bei EQS abrufen


Pflegeeinrichtungen , 659510 , MED , XETR:MED